AstraZeneca: Tezspire Trial Shows Reduced Polyp Size
Tezspire met primary endpoints in Phase III trial for chronic rhinosinusitis with nasal polyps, showing significant reduction in polyp size and congestion.
Tezspire met primary endpoints in Phase III trial for chronic rhinosinusitis with nasal polyps, showing significant reduction in polyp size and congestion.
International Consolidated Airlines Group announces a €350 million share buyback program.
Richemont reported stable sales of €10.1 billion and a 21.9% operating margin for the six months ending 30 September 2024, despite macroeconomic challenges.
SUSTAINera expands in North America, focusing on economical and responsible solutions through the 4Rs: Remanufacturing, Repair, Reuse, Recycle.
Nicolas Notebaert is now the CEO of Concessions at VINCI according to a new press release, as Pierre Coppey steps down.
Entain appoints Dafne Guisard as Chief Operations Officer, effective from January 13, 2025.
The Coca-Cola Company announces its participation in the Morgan Stanley Global Consumer & Retail Conference. For more details, visit their website.
Ferrari N.V. signed a partnership with IBM through its subsidiary Ferrari S.p.A.
Merck and Intel have launched a European academic research program with 11 institutions across six countries to develop sustainable semiconductor manufacturing using AI.
STMicroelectronics and ENGIE signed a 21-year agreement for renewable energy supply from a new solar farm in Malaysia to support ST's carbon neutrality…